Occudo Quantitative Strategies’s Transmedics TMDX Stock Holding History

Occudo Quantitative Strategies’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,577	Closed	-$313K	–	922
2025 Q4	$313K	Sell	2,577 -6,229	-71%	-$782K	0.02%	495
2025 Q3	$988K	Buy	8,806 +3,895	+79%	+$456K	0.12%	236
2025 Q2	$658K	Buy	+4,911	New	+$539K	0.07%	316
2024 Q4	–	Sell	-3,847	Closed	-$604K	–	951
2024 Q3	$604K	Sell	3,847 -2,548	-40%	-$393K	0.11%	234
2024 Q2	$963K	Buy	6,395 +2,885	+82%	+$346K	0.17%	167
2024 Q1	$260K	Buy	+3,510	New	+$289K	0.05%	510
2023 Q4	–	Sell	-19,042	Closed	-$1.04M	–	1198
2023 Q3	$1.04M	Buy	19,042 +10,548	+124%	+$759K	0.13%	241
2023 Q2	$713K	Sell	8,494 -1,763	-17%	-$135K	0.07%	421
2023 Q1	$777K	Sell	10,257 -15,613	-60%	-$1.08M	0.07%	390
2022 Q4	$1.6M	Sell	25,870 -482	-2%	-$25.6K	0.19%	167
2022 Q3	$1.1M	Buy	+26,352	New	+$1.15M	0.09%	369

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's TMDX Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 2,577 shares — an estimated $313K sold.

Occudo Quantitative Strategies first reported a position in TMDX in Q3 2022 and held it in 11 quarters. The position peaked at $1.6M in Q4 2022. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Occudo Quantitative Strategies reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Occudo Quantitative Strategies sold 2,577 Transmedics shares in Q1 2026, an estimated $313K.
Occudo Quantitative Strategies first reported a position in Transmedics in Q3 2022 and held it in 11 quarters.
Occudo Quantitative Strategies's Transmedics position peaked at $1.6M in Q4 2022.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.